Dacula, GA- January 11, 2024- Hamilton Plaza Animal Hospital (HPAH), aleading provider of comprehensive veterinary services, is excited to announce that January is recognized as Arthritis Awareness Month.

As part of Arthritis Awareness Month, HPAH is offering a special promotion. Throughout January, we are providing a 10% discount on Librela and Solensia injections, highly effective treatments for managing arthritis in pets.This offer is in line with our mission to make quality pet healthcare more accessible to all pet parents.

The team at Hamilton Plaza Animal Hospital invites everyone to take advantage of this special offer and join them in spreading awareness about arthritis in pets. For more information, please visit our website at https://hpahospital.com/.

About Hamilton Plaza Animal Hospital:

Hamilton Plaza Animal Hospital is dedicated to providing the highest level of veterinary care to pets.With a team of compassionate and experienced professionals, we ensure that every pet gets the personalized care they deserve.

Press Contact:

Dr. Tara Zak

This email address is being protected from spambots. You need JavaScript enabled to view it.

MARINA DEL RAY, CA - January 11th, 2024 - Best Gold IRA Companies, a groundbreaking new venture led by Joshua Earp, is revolutionizing the world of precious metal individual retirement accounts (IRAs). Their advanced tools empower investors to make well-informed decisions, identify the best gold IRA organizations, and secure their future. Joshua Earp, a seasoned precious metals investor with over 15 years of experience, founded Best Gold IRA Companies to provide individuals with critical insights.

The team of committed experts has gathered extensive research, enabling investors to examine customer feedback, evaluate the reputations of different custodians, and explore the details of agreements. Unlike conventional investment firms, Best Gold IRA Companies surpass expectations by carefully selecting financial stability, crafting portfolios, and protecting wealth.

With the current economic uncertainty, investors are considering alternative investment options to protect and diversify their wealth. Gold IRAs are popular for individuals seeking to safeguard their retirement savings. Gold is a valuable and stable asset with a history of hedging against inflation and economic downturns.

Investing in gold IRAs offers several advantages. Gold has a strong track record and often outperforms traditional investments during volatility. Gold IRAs provide a tangible asset not subject to the same risks as stocks and bonds. This can give a sense of security to investors concerned about the stability of the financial markets.

However, clients need to understand the potential drawbacks of gold IRAs. While gold is a reliable store of value, it can experience significant fluctuations. Fluctuations impact the portfolio value. With meticulous gold IRA reviews, investors get the pros and cons of each organization, enabling them to make informed choices.

When clients work with Joshua and his team, they receive:

• Unmatched Expertise and Guidance: Best Gold IRA Companies boasts a team of seasoned experts who carefully navigate the complex seas of precious metals. Their wealth of knowledge allows them to tailor strategies that align with each investor's unique financial aspirations.

• A Partner For Building Wealth: Whether you're a seasoned investor or new to the world of precious metals, Best Gold IRA Companies is a reliable partner in prosperity. They craft solutions that fit their client's individual needs, ensuring that success is their mission.

• Transparency is Crucial: Trust is the foundation of their relationship with clients. Best Gold IRA Companies believes in transparency at every step.

The Best Gold IRA Company is not just an investment organization. They are a vehicle for financial prosperity. Their vision is to combine the brilliance of precious metals with the promise of lasting wealth. Join Joshua Earp and his team on this transformative journey, where they redefine the investment experience.

SGS, the world’s leading testing, inspection and certification company, has published an overview of a proposal by the US Congress to ban the procurement of products containing perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS).

Introduced in July 2023, the proposed act – S.2283 ‘PFAS-Free Procurement Act of 2023’ – would prohibit executive agencies from entering into new procurement contracts for selected products if they contain either substance.

Products within the scope of the proposal:
- Non-stick cookware and cooking utensils
- Furniture, carpets and rugs treated with stain-resistant coatings

The act also directs executive agency heads to prioritize the procurement of products that do not contain any per- or polyfluoroalkyl substances (PFAS) at all.

The proposed effective date for the act is October 1, 2025.

SGS Chemical Testing
SGS offers a comprehensive range of testing services to help manufacturers and suppliers ensure their products are safe and comply with national and international regulations concerning harmful chemicals. In the end, it’s only trusted because it’s tested. Learn more about SGS Chemical Testing Services.

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full US Congress Proposes Procurement Ban for Products Containing PFAS SafeGuardS.

Subscribe here to receive SGS SafeGuardS direct to your inbox.

For further information contact:

Dr. HingWo Tsang
Global Information and Innovation Manager
Tel: (+852) 2774 7420

Melanie Tamayo
Senior Technical Manager, SGS NA.
Tel: + 1 312 414 9394

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Website: www.sgs.com/hardlines
LinkedIn: SGS Connectivity & Products

About SGS
We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 98,000 employees operate a network of 2,650 offices and laboratories, working together to enable a better, safer and more interconnected world.

Wilmington, DE – A unique medication-free pathway out of depression, anxiety, OCD, and PTSD has been developed for patients of Brandywine Valley TMS in Wilmington, Delaware.

Brandywine Valley TMS utilizes cutting-edge technology for the treatment of neuropsychiatric disorders. This local TMS clinic provides Transcranial Magnetic Stimulation (TMS) therapy for depression, anxiety, OCD and PTSD for patients who are seeking treatment options other than medication and psychotherapy. 

"Our goal is to improve our patients’ mental healthby providing this novel and medication-free treatment called TMS, or transcranial magnetic stimulation therapy.This is a different approach for patients with conditions such as depression that, for whatever reason, have not done well on medications or simply prefer not to take medications. " said clinic founder, Dr Jack Castro, a Clinical TMS Society member who is also certified by the American Board of Psychiatry and Neurology.

TMS therapy, which is FDA-approved and covered by most insurances, uses magnetic pulses to stimulate specific brain regions linked to depression. This non-invasive treatment has shown promising results in relieving depression symptoms for individuals resistant to traditional therapies. The magnetic pulses modulate neural activity, normalizing mood-regulating circuits, and promote sustained improvements in overall mental well-being.

Dr Castro said: "TMS is a simple outpatient therapy in which most patients experience positive changes after just a few sessions. Sessions are relaxing as they are performed withthe patient sitting in a reclining chair listening to music or watching TV, while a magnetic coil stimulates the patient’s brain cortex and its neurons."

His approach has been highly effective for numerous patients, including that of James, a 36-year-old patient, who presented with ADHD, inattentive type, and cyclothymia, a milder form of bipolar disorder. His treatment history included a moderately complex medication regimen. Despite this, his mood oscillated between relative normalcy and severe dysfunction.

In 2023, after acquiring a MagVenture TMS system, Dr Castro suggested TMS therapy treatment after establishing a strong patient-physician relationship with James. Remarkably, after just 13 sessions, James reported a significant lift in his mood, and to further optimize his treatment, the TMS parameters were adjusted, increasing the pulse count and adapting the intensity accordingly to enhance his low mood.

By his 36th session, James had substantially improved his patient health assessment or PHQ-9. He continues bi-weekly TMS sessions and maintains his initial medication regimen, finding a new lease on life under the clinic's care.

"His journey, marked by trust and perseverance, is a testament to the potential of TMS in managing severe depression as well as other milder forms depression," said Dr Castro. "This highlights the transformative impact of TMS, especially in cases where traditional medication approaches face limitations. James's story is a powerful TMS therapy review or testimonial, showcasing real patient results."

To schedule an appointment at Brandywine Valley TMS, call (302) 635-1710 or discover more at https://www.brandywinevalleytms.com.